Medicare Enrolled

Dr. John Ibrahim, M.D.

Family Medicine · New Port Richey, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
8133 STATE ROAD 54, New Port Richey, FL 34655
7273723750
In practice since 2006 (19 years)
NPI: 1669555470 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ibrahim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ibrahim? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ibrahim

Dr. John Ibrahim is a family medicine in New Port Richey, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ibrahim performed 48,673 Medicare services across 2,415 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ibrahim received a total of $14,392 from 60 pharmaceutical and/or device companies across 715 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ibrahim is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 0% volume in FL$ $14,392 industry payments

Medicare Practice Summary

Medicare Utilization ↗
48,673
Medicare services
Top 0% in FL for family medicine
2,415
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,562 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection40,601$0$0
Denosumab injection (Prolia/Xgeva)1,380$18$44
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg1,320$13$29
Office visit, established patient (30-39 min)1,243$92$209
Drug injection, under skin or into muscle402$10$48
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes287$29$57
Steroid injection (triamcinolone)253$1$3
Injection, lidocaine hcl for intravenous infusion, 10 mg230$0$1
Advance care planning consultation, first 30 min211$58$160
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes202$26$52
Annual alcohol misuse screening, 5 to 15 minutes201$18$35
Annual depression screening196$18$36
Dexamethasone injection (steroid)196$0$1
Testing for presence of drug, read by direct observation191$12$25
Office visit, established patient, complex (40-54 min)189$132$281
Annual wellness visit, follow-up182$125$219
Hemoglobin A1c test (diabetes monitoring)152$10$22
Remote patient monitoring management, 20 min/month151$36$76
Electrocardiogram (EKG), 12-lead131$10$38
Ceftriaxone antibiotic injection130$0$2
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg124$1$5
Chronic care management, first 20 min/month82$34$120
Injection, ketorolac tromethamine, per 15 mg82$0$1
Automated urinalysis74$2$5
Remote patient monitoring device, 30 days71$36$92
Joint injection, major joint69$55$142
Face-to-face behavioral counseling for obesity, 15 minutes64$25$52
Transitional care management services for problem of high complexity61$209$462
Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b42$137$288
Inhalation treatment for airway obstruction or sputum production23$6$35
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and23$40$105
Injection of trigger points, 3 or more muscles21$43$124
Removal of impacted ear wax19$35$104
Transitional care management services for problem of at least moderate complexity18$157$327
New patient office visit, complex (60-74 min)16$173$404
New patient office visit (45-59 min)13$120$326
Blood glucose (sugar) test performed by hand-held instrument12$3$5
Urine microalbumin (protein) analysis11$6$10
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
91.6% medium
7.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,392
Total received (2018-2024)
Avg $2,056/year across 7 years
Top 2% in FL for family medicine
60
Companies
715
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,392 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,804
2023
$1,784
2022
$3,556
2021
$3,066
2020
$1,577
2019
$1,431
2018
$1,173

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,529
Novo Nordisk Inc
$1,508
GlaxoSmithKline, LLC.
$978
Lilly USA, LLC
$973
Esperion Therapeutics, Inc.
$843
Amgen Inc.
$751
Boehringer Ingelheim Pharmaceuticals, Inc.
$596
Bayer HealthCare Pharmaceuticals Inc.
$560
PFIZER INC.
$499
Abbott Laboratories
$407
Amarin Pharma Inc.
$387
Merck Sharp & Dohme Corporation
$387
Medtronic Vascular, Inc.
$328
Corcept Therapeutics
$314
Biohaven Pharmaceutical Holding Company Ltd.
$292
Bausch Health US, LLC
$258
Intuitive Surgical, Inc.
$243
Biohaven Pharmaceuticals, Inc.
$200
ABBVIE INC.
$183
MEDICOMP INC
$159
Eisai Inc.
$136
Teva Pharmaceuticals USA, Inc.
$125
Novartis Pharmaceuticals Corporation
$124
Zyla Life Sciences
$117
Edwards Lifesciences Corporation
$110
Bayer Healthcare Pharmaceuticals Inc.
$102
EISAI INC.
$82
Helsinn Therapeutics (U.S.), Inc.
$78
Aclaris Therapeutics, Inc.
$76
Axonics, Inc.
$71
Zyla Life Sciences, Inc.
$70
JAZZ PHARMACEUTICALS INC.
$69
Merck Sharp & Dohme LLC
$63
Janssen Pharmaceuticals, Inc
$59
Medtronic, Inc.
$51
AbbVie Inc.
$50
Vanda Pharmaceuticals Inc.
$49
Inspire Medical Systems, Inc.
$47
Bioventus LLC
$44
Currax Pharmaceuticals LLC
$43
IDORSIA PHARMACEUTICALS US INC
$42
Grifols USA, LLC
$42
Phadia US Inc.
$37
Acerus Pharmaceuticals Corporation
$29
Indivior Inc.
$26
Acella Pharmaceuticals, LLC
$21
Horizon Therapeutics plc
$21
WATERMARK MEDICAL, INC.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Alexion Pharmaceuticals, Inc.
$19
Lucid Diagnostics Inc.
$18
Astellas Pharma US Inc
$18
E.R. Squibb & Sons, L.L.C.
$17
FIDIA PHARMA USA INC.
$17
Nabriva Therapeutics, plc
$16
Watermark Medical, Inc.
$15
Allergan Inc.
$15
Fidia Pharma USA Inc.
$15
IBSA Pharma Inc.
$13
Seqirus USA Inc
$11
Top 3 companies account for 34.8% of total payments
Associated products mentioned in payments ›
3F · AIRSUPRA · AJOVY · ANORO · APLENZIN · ARES 620 UNICORDER · ARES HOME SLEEP TESTING DEVICE · AREXVY · Aimovig · Axonics · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Belviq · CHANTIX · COMIRNATY · CONTRAVE · Da Vinci Surgical System · Dayvigo · Durolane · ELIQUIS · EMGALITY · EMPRINT · ENTRESTO · EVENITY · Edwards SAPIEN 3 Transcatheter Heart Valve · Endurant · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · HETLIOZ · HYMOVIS · Hymovis · INSPIRE · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MITRACLIP · MOUNJARO · MitraClip System · NEXLETOL · NEXLIZET · NP Thyroid 60 · NURTEC ODT · Natesto · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C Liquid · Prolia · QULIPTA · QUVIVIQ · RHOFADE · RYBELSUS · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · SPRIX · STIOLTO · STIOLTO RESPIMAT · SUBLOCADE · SUNOSI · SYMBICORT · Saxenda · TAVNEOS · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tresiba · UBRELVY · ULTOMIRIS · VALCHLOR · VIIBRYD · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xenleta · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in FL.

Equivalent to $30 per 100 Medicare services performed
Looking for a family medicine in New Port Richey?
Compare family medicines in the New Port Richey area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
885
Per 100K population
150.3
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ibrahim is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ibrahim experienced with testosterone injection?
Based on Medicare claims data, Dr. Ibrahim performed 40,601 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ibrahim receive payments from pharmaceutical companies?
Yes. Dr. Ibrahim received a total of $14,392 from 60 companies across 715 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ibrahim's costs compare to other family medicines in New Port Richey?
Dr. Ibrahim's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ibrahim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →